RecruitingNCT05908708

Closed-loop Medtronic 780G System in Youth With Type 1 Diabetes

Title: Closed-loop Medtronic 780G System in Youth With Type 1 Diabetes: AWeSoMe Study Group Prospective Trial

Sponsor

Sheba Medical Center

Enrollment

120 participants

Start Date

Jun 1, 2023

Study Type

OBSERVATIONAL

Conditions

Type 1 Diabetes Child, Only

Summary

The goal of this observational study is to describe data on Israeli children and youth using the 780G system including data regarding glycemic control parameters, various questionnaires, sleep data, bioimpedance measures, and dietary parameters. The main questions it aims to answer are: • whether the 780G system will improve glycemic control • whether the psychosocial aspects will improve. Participants will be followed once connected to 780G, at baseline, one, three, six months, 1 year, and two years after the connection.

Eligibility

Min Age: 1 YearMax Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Medtronic 780G® hybrid closed loop for people with child, only and type 1 diabetes. The study is currently recruiting participants at 1 location. People eligible for this study include aged 1 Year to 21 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.